Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.83 |
| ▸ | CA9 | Q16790 | 1/20 | 0.83 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | FKBP4 | Q02790 | 3/20 | 0.33 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.33 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5425695 | 1.00 | CA1 (0.83) | CA1CA9ALDH1A1TSHRLMNA | |
| SCHEMBL31745772 | 1.00 | CA1 (0.83) | CA1CA9ALDH1A1TSHRLMNA | |
| SCHEMBL18695004 | 1.00 | CA1 (0.83) | CA1CA9ALDH1A1TSHRLMNA | |
| SCHEMBL6336708 | 1.00 | CA1 (0.83) | CA1CA9ALDH1A1TSHRLMNA | |
| SCHEMBL876542 | 0.97 | CA1 (0.88) | CA1CA9ALDH1A1TSHRLMNA | |
| SCHEMBL189541 | 0.94 | CA1 (0.94) | CA1CA9ALDH1A1TSHRLMNA | |
| SCHEMBL7053729 | 0.94 | CA1 (0.94) | CA1CA9ALDH1A1TSHRLMNA | |
| SCHEMBL18695005 | 0.94 | CA1 (0.94) | CA1CA9ALDH1A1TSHRLMNA | |
| SCHEMBL6346930 | 0.94 | CA1 (0.94) | CA1CA9ALDH1A1TSHRLMNA | |
| SCHEMBL7055908 | 0.94 | CA1 (0.94) | CA1CA9ALDH1A1TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250380688-A1 | SUSTAINED RELEASE PHEROMONE PREPARATION AND CONTROL METHOD USING THE SAME | SHINETSU CHEMICAL CO (JP) | 2025-12-18 | — | — | US | disclosed |
| US-20250250418-A1 | MIXTURE FOR INHIBITING THE EMISSION OF ALDEHYDES FROM POLYURETHANE FOAM FOR AN EXTENDED PERIOD OF TIME | HUNTSMAN PETROCHEMICAL LLC | 2025-08-07 | — | — | US | disclosed |
| EP-4508111-A1 | MIXTURE FOR INHIBITING THE EMISSION OF ALDEHYDES FROM POLYURETHANE FOAM FOR AN EXTENDED PERIOD OF TIME | Huntsman Petrochemical LLC (US) | 2025-02-19 | — | — | EP | disclosed |
| WO-2023200641-A1 | MIXTURE FOR INHIBITING THE EMISSION OF ALDEHYDES FROM POLYURETHANE FOAM FOR AN EXTENDED PERIOD OF TIME | HUNTSMAN PETROCHEMICAL LLC (US) | 2023-10-19 | — | — | WO | disclosed |
| CN-116864791-A | Long carbon chain fluorinated polyester-based polymer electrolyte and preparation method and application thereof | 北京化工大学 | 2023-10-10 | — | — | CN | disclosed |
| CN-116774541-A | Toner comprising reactive charge control agent | 施乐公司 | 2023-09-19 | — | — | CN | disclosed |
| US-11542359-B2 | Photoresponsive polyurethanes | THE UNIVERSITY OF AKRON (US) | 2023-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250380688-A1 | SUSTAINED RELEASE PHEROMONE PREPARATION AND CONTROL METHOD USING THE SAME | GNRHR, GHRHR, SHBG | CA1 117/4885CA9 198/4885ALDH1A1 2877/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.